ValiRx plc (LON:VAL – Get Free Report) dropped 12.1% during mid-day trading on Friday . The company traded as low as GBX 0.62 ($0.01) and last traded at GBX 0.62 ($0.01). Approximately 1,954,122 shares were traded during trading, a decline of 67% from the average daily volume of 5,980,873 shares. The stock had previously closed at GBX 0.70 ($0.01).
ValiRx Trading Down 12.1%
The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.44. The firm has a 50-day moving average of GBX 0.56 and a two-hundred day moving average of GBX 0.60. The firm has a market capitalization of £2.33 million, a P/E ratio of -0.41 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Friday, June 6th. The company reported GBX (1.45) (($0.02)) earnings per share (EPS) for the quarter. ValiRx had a negative return on equity of 55.84% and a negative net margin of 20,554.01%. On average, analysts anticipate that ValiRx plc will post -1.74 EPS for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Insider Trades May Not Tell You What You Think
- PepsiCo Bottomed Out—Time to Chugalug This Blue-Chip Buy?
- What is the S&P/TSX Index?
- Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?
- How Technical Indicators Can Help You Find Oversold Stocks
- These 3 Rare Earth Stocks Are Surging Alongside MP Materials
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
